A whole series of photosensitisers including fullerene C60 and its derivatives is able to inactivate various types of viruses and, particularly, human immunodeficiency virus (HIV).
The exact mechanisms of photodynamic virus inactivation remains obscure and may, conceivably, involve direct damaging effect of 1Î2, cleavage of viral DNA, and formation of new crosslinks in viral membrane and capsid proteins.
Taking into account viral theory of atherosclerosis suggesting the key etiological role of cytomegalo- and herpesviruses, it seems logical to assume that PDT of coronary vessels with fullerenes may theoretically be a useful tool in prevention of atherosclerosis. However, the detailed investigation of photodynamic antiviral effects of fullerenes is required to validate this concept.
In the last two decades, buckminsterfullerene, or fullerene C60, has drawn considerable scientific attention due to its unique physical and chemical properties. The compelling research by Syrensky, Egorova, Alexandrov, and Galagudza probes deeper into the potential cardiovascular applications of these fascinating nanostructures. Their review encompasses the potential of fullerenes in mitigating ischemia-reperfusion injury, influencing vascular tone, and their potential in photodynamic therapy for cardiovascular diseases.
The antioxidative effects of fullerenes take center stage in this paper, opening up a new vista of possibilities in treating cardiovascular ailments. The researchers' groundbreaking findings propose fullerenes' anti-ischemic effects, vasodilatation, inhibition of low-density lipoprotein oxidation, and the limitation of the proliferative activity of vascular smooth muscle cells. This proposes a new therapeutic approach towards cardiovascular health, particularly in conditions like atherosclerosis.
The article also touches on the intriguing concept of using fullerenes as photosensitizers to potentially inactivate various viruses, including the human immunodeficiency virus (HIV). Although the mechanism remains hazy, this could have far-reaching implications, even offering a new approach in atherosclerosis prevention. As the body of evidence grows, fullerene derivatives reaffirm their potential as game-changers in cardiovascular therapy. Future studies focusing on the molecular mechanisms of their observed effects would be a valuable addition to the existing knowledge pool.